Biology subjects

Tsao, N.

Publications and source records attributed to Tsao, N..

4 recordsLinked to original sources

bioRxiv2026

Helicase family proteins promote antiviral ADP-ribosylation of DNA purines

DarTG defense systems studied to date contain a DarT1 or DarT2 toxin that blocks phage replication by ADP-ribosylating DNA and a NADAR or macrodomain antitoxin, DarG, that reverses this modification at homeostasis. Here, we identify additional DarTG subfamilies, one of which comprises a DarT3 toxin, an ADP-ribosylhydrolase (ARH)-domain antitoxin, and a helicase family protein, DarH. The Escherichia coli DarHTG3 system confers broad phage defense, requires DarH and, unlike previously characterized DarTG systems, modifies adenine. Characterization of additional DarH-containing DarTG systems reveals that a subset also target guanine. Our data support a model in which ADP-bound DarH functions as a processivity factor by recruiting DarT to its single-stranded DNA substrate and allowing for ADP-ribosylation of multiple target sites. These findings reveal how a helicase family protein regulates an antiviral effector by promoting DNA engagement rather than unwinding and thereby expanding the functional repertoire of helicase family proteins in bacterial immunity.

microbiology↗

bioRxiv2025

Human MutLa activates methylpurine DNA glycosylase to induce alkylation damage cytotoxicity

Alkylation chemotherapy is commonly used against tumors such as glioblastoma, yet resistance often develops through downregulation of mismatch repair (MMR). Previous work has established that loss of MMR prevents the excision of the thymine-containing strand across O6meG-T mismatches. Thus, MMR dysfunction is advantageous because it prevents a vicious cycle of attempted repair that leads to cell death. Here, we provide an alternative explanation to this prevailing mechanism of alkylation chemoresistance by MMR loss. We find that the MMR protein MutL physically and functionally interacts with the base excision repair (BER) enzyme methylpurine DNA glycosylase (MPG), which processes common alkylation adducts, such as 7meG and 3meA. Biochemical reconstitution demonstrates that MutL activates MPG glycosylase activity at least partly by promoting MPG substrate binding. This glycosylase stimulation requires ATP hydrolysis as well as the MLH1-interacting region on MPG. Both MutL or its ability to interact with MPG promote the generation of alkylation-induced abasic sites in cells, which contribute to the cytotoxicity of methyl methanesulfonate (MMS), an SN2 alkylating agent which does not produce O6meG. Our results provide new insight into the mechanism of alkylation chemoresistance and uncover an unappreciated crosstalk between MMR and base excision repair.

biochemistry↗

bioRxiv2024

YTHDC1 cooperates with the THO complex to prevent RNA damage-induced DNA breaks

Certain environmental toxins are nucleic acid damaging agents, as are many chemotherapeutics used for cancer therapy. These agents induce various adducts in DNA as well as RNA. Indeed, most of the nucleic acid adducts (>90%) formed due to these chemicals, such as alkylating agents, occur in RNA1. However, compared to the well-studied mechanisms for DNA alkylation repair, the biological consequences of RNA damage are largely unexplored. Here, we demonstrate that RNA damage can directly result in loss of genome integrity. Specifically, we show that a human YTH domain-containing protein, YTHDC1, regulates alkylation damage responses in association with the THO complex (THOC)2. In addition to its established binding to N6-methyladenosine (m6A)-containing RNAs, YTHDC1 binds to N1-methyladenosine (m1A)-containing RNAs upon alkylation. In the absence of YTHDC1, alkylation damage results in increased alkylation damage sensitivity and DNA breaks. Such phenotypes are fully attributable to RNA damage, since an RNA-specific dealkylase can rescue these phenotypes. These RNA damage-induced DNA breaks (RDIBs) depend on R-loop formation, which in turn are processed by factors involved in transcription-coupled nucleotide excision repair. Strikingly, in the absence of YTHDC1 or THOC, an RNA m1A methyltransferase targeted to the nucleus is sufficient to induce DNA breaks. Our results uncover a unique role for YTHDC1-THOC in base damage responses by preventing RDIBs, providing definitive evidence for how damaged RNAs can impact genomic integrity.

molecular biology↗

bioRxiv2020

Aberrant RNA methylation triggers recruitment of an alkylation repair complex

A critical question in genome stability is the nature of the chemical damage responsible for repair activation. We previously reported a novel pathway specifically activated during alkylation damage in human cells, where the E3 ubiquitin ligase RNF113A mediates the recruitment of the ASCC repair complex. Yet the mechanistic basis for the alkylation damage selectivity of this pathway remains unclear. Here, we demonstrate that RNA but not DNA alkylation is the initiating signal for this process. Aberrantly methylated RNA is sufficient to recruit ASCC, while an RNA dealkylase suppresses ASCC recruitment during chemical alkylation. This aberrant RNA methylation causes transcriptional repression in a manner dependent on the ASCC complex. We show that an alkylated pre-mRNA, or an RNA containing a single damaged base, is sufficient to activate RNF113A E3 activity in a phosphorylation-dependent manner. Together, our work identifies an unexpected role for RNA damage in eliciting a DNA repair response, and suggests that RNA may serve as the "canary in the coal mine" for sensing alkylation damage.

molecular biology↗